| Vatsal Bajpai, MD | |
|
2325 18th St Ste 130, Columbus, IN 47201-5387 | |
| (812) 379-2020 | |
| Not Available |
| Full Name | Vatsal Bajpai |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 2325 18th St Ste 130, Columbus, Indiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013398353 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 01080380A (Indiana) | Primary |
| 207R00000X | Internal Medicine | 11018349A (Indiana) | Secondary |
| Entity Name | Eskenazi Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730451063 PECOS PAC ID: 4284546813 Enrollment ID: O20031103000440 |
News Archive
To ensure that they receive proper care after surgery, patients are frequently referred by hospitals to inpatient facilities such as skilled nursing homes or inpatient rehabilitation centers or to receive home health care and other outpatient services. This type of care, called post-acute care, now accounts for some $62 billion in annual Medicare spending.
The U.S. Food and Drug Administration announced today that federal judge Algenon L. Marbley of the Southern District of Ohio has approved a consent decree of permanent injunction against Shamrock Medical Solutions Group, LLC, of Lewis Center, Ohio, and four of its corporate officers and employees for continued drug manufacturing and labeling violations that resulted in the distribution of mislabeled drugs.
USANA Health Sciences, Inc. is proud to announce its partnership with the Utah Grizzlies as the team's official nutritional supplement provider.
The most recent results from a clinical trial show that ibrutinib, a newly approved drug for Waldenstrom's Macroglobulinemia, continued to control the rare blood cancer, with 95 percent of patients surviving for two years, report investigators from Dana-Farber Cancer Institute.
› Verified 9 days ago
| Entity Name | The Health And Hospital Corporation Of Marion County |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104027879 PECOS PAC ID: 6709795974 Enrollment ID: O20041229000426 |
News Archive
To ensure that they receive proper care after surgery, patients are frequently referred by hospitals to inpatient facilities such as skilled nursing homes or inpatient rehabilitation centers or to receive home health care and other outpatient services. This type of care, called post-acute care, now accounts for some $62 billion in annual Medicare spending.
The U.S. Food and Drug Administration announced today that federal judge Algenon L. Marbley of the Southern District of Ohio has approved a consent decree of permanent injunction against Shamrock Medical Solutions Group, LLC, of Lewis Center, Ohio, and four of its corporate officers and employees for continued drug manufacturing and labeling violations that resulted in the distribution of mislabeled drugs.
USANA Health Sciences, Inc. is proud to announce its partnership with the Utah Grizzlies as the team's official nutritional supplement provider.
The most recent results from a clinical trial show that ibrutinib, a newly approved drug for Waldenstrom's Macroglobulinemia, continued to control the rare blood cancer, with 95 percent of patients surviving for two years, report investigators from Dana-Farber Cancer Institute.
› Verified 9 days ago
| Entity Name | Columbus Regional Health Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336510098 PECOS PAC ID: 1052612314 Enrollment ID: O20151211000054 |
News Archive
To ensure that they receive proper care after surgery, patients are frequently referred by hospitals to inpatient facilities such as skilled nursing homes or inpatient rehabilitation centers or to receive home health care and other outpatient services. This type of care, called post-acute care, now accounts for some $62 billion in annual Medicare spending.
The U.S. Food and Drug Administration announced today that federal judge Algenon L. Marbley of the Southern District of Ohio has approved a consent decree of permanent injunction against Shamrock Medical Solutions Group, LLC, of Lewis Center, Ohio, and four of its corporate officers and employees for continued drug manufacturing and labeling violations that resulted in the distribution of mislabeled drugs.
USANA Health Sciences, Inc. is proud to announce its partnership with the Utah Grizzlies as the team's official nutritional supplement provider.
The most recent results from a clinical trial show that ibrutinib, a newly approved drug for Waldenstrom's Macroglobulinemia, continued to control the rare blood cancer, with 95 percent of patients surviving for two years, report investigators from Dana-Farber Cancer Institute.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vatsal Bajpai, MD Po Box 775383, Chicago, IL 60677-5383 Ph: (812) 376-5315 | Vatsal Bajpai, MD 2325 18th St Ste 130, Columbus, IN 47201-5387 Ph: (812) 379-2020 |
News Archive
To ensure that they receive proper care after surgery, patients are frequently referred by hospitals to inpatient facilities such as skilled nursing homes or inpatient rehabilitation centers or to receive home health care and other outpatient services. This type of care, called post-acute care, now accounts for some $62 billion in annual Medicare spending.
The U.S. Food and Drug Administration announced today that federal judge Algenon L. Marbley of the Southern District of Ohio has approved a consent decree of permanent injunction against Shamrock Medical Solutions Group, LLC, of Lewis Center, Ohio, and four of its corporate officers and employees for continued drug manufacturing and labeling violations that resulted in the distribution of mislabeled drugs.
USANA Health Sciences, Inc. is proud to announce its partnership with the Utah Grizzlies as the team's official nutritional supplement provider.
The most recent results from a clinical trial show that ibrutinib, a newly approved drug for Waldenstrom's Macroglobulinemia, continued to control the rare blood cancer, with 95 percent of patients surviving for two years, report investigators from Dana-Farber Cancer Institute.
› Verified 9 days ago
Melissa Andrea Martinez Mateo, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2326 18th St Ste 210, Columbus, IN 47201 Phone: 812-372-8680 | |
Neil Amin, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2400 17th St, Columbus, IN 47201 Phone: 812-376-5974 | |
Dr. Nandu Gourineni, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2325 18th St Ste 130, Columbus, IN 47201 Phone: 812-379-2020 Fax: 812-378-8267 | |
Lawrence Klein, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2325 18th St Ste 130, Columbus, IN 47201 Phone: 812-379-2020 Fax: 812-378-8267 | |
Chelsie Lynn Brady, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2400 17th St, Columbus, IN 47201 Phone: 812-376-5974 Fax: 812-375-3203 | |
Brian M Kline, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 815 Schnier St, Columbus, IN 47201 Phone: 912-375-8810 |